Cannabinoids Are Test Case For US FDA Advisors’ ‘Predicted Pharmacological Activity’ Discussion

/
/

The FDA prompts the CBD test case discussion with two questions, both framed with guiding parameters: “How might a public health agency assess the …

  • Facebook
  • Twitter
  • Google+
  • Linkedin
  • Pinterest
This div height required for enabling the sticky sidebar